Morrison Foerster advised NuCicer, a pioneer in chickpea breeding innovation and sustainable ingredient solutions, in its $11.5 million Series A funding round led by Rhapsody Venture Partners, with participation from Leaps by Bayer and a series of new investors for the company including Illumina Ventures, Better Ventures, Stray Dog Capital, and a leading global food company.
The investment will scale production of NuCicer’s existing high-protein chickpea variety to meet growing demand for minimally processed flour and protein ingredients as well as fund next-generation chickpea breeding. NuCicer’s breakthrough varieties offer up to 35% protein content – compared to 21% commodity baseline, while also delivering high fiber and lower fat, enabling 2-for-1 fortification strategies for food brands seeking simpler, cleaner-label protein and fiber solutions.
The MoFo team advising NuCicer was led by San Francisco corporate partner Brad Kondracki and corporate associates Justin Wood and Kimberly Valladares.
Read the NuCicer’s press release.